Search
for
Sort by
Research 30 of 1000+
- 28665 Cutaneous T-cell lymphoma (CTCL) outcomes during COVID-19
- C001 Lymphoproliferative disorders
- Unusual Clinical Presentation of a Primary Cutaneous Follicle Center Lymphoma on the Scalp of a Middle-Aged Female: Case Report and Review of the Literature
- Oral Presentations
- Scalp Involvement in Primary Cutaneous Lymphomas—An Update on Clinical Presentation, Diagnostics, and Management
- Hodgkin′s lymphoma presenting as alopecia
- National scientific medical meeting 1996 abstracts
- What’s New in the Histologic Evaluation of Alopecia and Hair-Related Disorders?
- British Society for Dermatopathology
- INTERFERONS IN DERMATOLOGY
- Cetuximab-induced hypertrichosis of the scalp and eyelashes
- Posters Presented at the 19th Joint Meeting of the International Society of Dermatopathology, March 2–3, 2016, Hilton Crystal City at Washington Reagan National Airport, Arlington, Virginia, USA
- Advanced glycation end-products inhibit mesenchymal-epidermal interaction by up-regulating proinflammatory cytokines in hair follicles
- Folliculotropic Mycosis Fungoides: Update on Diagnosis, Clinicopathological Stage, and Management
- C003 Histopathology of the alopecias
- Correspondence
- Folliculotropic mycosis fungoides
- Oral cyclosporin does not arrest progression of androgenetic alopecia
- British Society for Dermatopathology: Summaries of Papers
- Significance of iron status in hair loss in women
- Dermoscopy — 4th Conference of the Section of Dermoscopy and Other Skin Imaging Techniques (DiTOS) of the Polish Dermatological Society — Abstracts
- Rapidly progressing mycosis fungoides presenting as follicular mucinosis
- TONGUE, RED
- Poster Presentations at the 28th Joint Meeting of the International Society of Dermatopathology, March 5–6, 2025, Orlando, Florida, USA
- Subject Index
- Recurrent pseudolymphomatous reaction to ear piercing: 20-year history
- Alopecia Mucinosa: Report of a Case and Review
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Mucocutaneous reactions to chemotherapy
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology